A Critical View on Lactose-Based Drug Formulation and Device Studies for Dry Powder Inhalation: Which Are Relevant and What Interactions to Expect?

Advanced Drug Delivery Reviews - Netherlands
doi 10.1016/j.addr.2011.04.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Preparation of Dry Powder Inhalation by Surface Treatment of Lactose Carrier Particles

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2003English

Changing to Dry Powder Inhalation Systems.

BMJ
1992English

Novel Dry Powder Inhalation System Based on Dispersion of Lyophilisates

European Journal of Pharmaceutical Sciences
Pharmaceutical Science
2011English

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study

Clinical Drug Investigation
MedicinePharmacology
2013English

Effect of Device Design and Formulation on the in Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers

AAPS Journal
Pharmaceutical Science
2015English

What to Expect When You Are Arrested: A Guide to Navigating for Unhoused Defendants

SSRN Electronic Journal
2018English

Investigation of Appropriate Inhalation Technique for Mometasone Furoate Dry Powder Inhaler

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2016English

Extrinsic Lactose Fines Improve Dry Powder Inhaler Formulation Performance of a Cohesive Batch of Budesonide via Agglomerate Formation and Consequential Co-Deposition

International Journal of Pharmaceutics
Pharmaceutical Science
2015English

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-Only Exposure System

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy